Calidi Biotherapeutics
CLDI
CLDI
35 hedge funds and large institutions have $656K invested in Calidi Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
6
Increased
4
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Citadel Advisors
Miami,
Florida
|
+$16.4K |
2 |
UBS Group
Zurich,
Switzerland
|
+$10.3K |
3 |
HF
HRT Financial
New York
|
+$10K |
4 |
Raymond James Financial
St Petersburg,
Florida
|
+$7.15K |
5 |
Goldman Sachs
New York
|
+$3.04K |
Top Sellers
1 |
AC
Armistice Capital
New York
|
-$582K |
2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18.5K |
3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$15.5K |
4 |
TSS
Two Sigma Securities
New York
|
-$11.5K |
5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$9.08K |